DiaMedica Therapeutics (DMAC) insider buying
17 open-market purchases of DMAC by DiaMedica Therapeutics's executives and directors since July 2025, worth $19M in total, from SEC Form 4 filings.
The most recent: Jan Stahlberg bought $626,458 on November 25, 2025.
The biggest buyer over the period is Jan Stahlberg: 17 purchases, $19M.
By year
| Year | Purchases | Value |
|---|---|---|
| 2025 | 17 | $19M |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Jan Stahlberg | 17 | $19M |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Nov 25, 2025 | Jan Stahlberg |
73,099 | $8.57 | $626,458 | Form 4 |
| Nov 24, 2025 | Jan Stahlberg |
40,253 | $7.89 | $317,596 | Form 4 |
| Nov 21, 2025 | Jan Stahlberg |
208,872 | $7.41 | $2M | Form 4 |
| Nov 20, 2025 | Jan Stahlberg |
128,426 | $7.41 | $951,637 | Form 4 |
| Nov 19, 2025 | Jan Stahlberg |
240,352 | $7.21 | $2M | Form 4 |
| Nov 18, 2025 | Jan Stahlberg |
182,882 | $6.75 | $1M | Form 4 |
| Nov 17, 2025 | Jan Stahlberg |
187,393 | $6.52 | $1M | Form 4 |
| Aug 27, 2025 | Jan Stahlberg |
50,772 | $6.00 | $304,632 | Form 4 |
| Aug 26, 2025 | Jan Stahlberg |
59,648 | $6.00 | $357,888 | Form 4 |
| Aug 25, 2025 | Jan Stahlberg |
338,265 | $6.00 | $2M | Form 4 |
| Aug 22, 2025 | Jan Stahlberg |
59,788 | $5.96 | $356,336 | Form 4 |
| Aug 21, 2025 | Jan Stahlberg |
48,172 | $5.96 | $287,105 | Form 4 |
| Aug 20, 2025 | Jan Stahlberg |
71,107 | $5.86 | $416,687 | Form 4 |
| Aug 15, 2025 | Jan Stahlberg |
8,233 | $6.00 | $49,398 | Form 4 |
| Aug 14, 2025 | Jan Stahlberg |
70,414 | $5.99 | $421,780 | Form 4 |
| Aug 13, 2025 | Jan Stahlberg |
293,601 | $5.91 | $2M | Form 4 |
| Jul 23, 2025 | Jan Stahlberg |
1,542,857 | $3.50 | $5M | Form 4 |
Questions
Are DiaMedica Therapeutics insiders buying the stock?
17 open-market purchases of DMAC by DiaMedica Therapeutics's executives and directors since July 2025, worth $19M in total, from SEC Form 4 filings. The most recent: Jan Stahlberg bought $626,458 on November 25, 2025.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From DiaMedica Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.